4ajw - Revision history

OCA at 11:28, 20 December 2023

2023-12-20T11:28:39Z

←Older revision		Revision as of 11:28, 20 December 2023
Line 3:		Line 3:
	<StructureSection load='4ajw' size='340' side='right'caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4ajw' size='340' side='right'caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/~~Lk3_transgenic_mice Lk3 transgenic mice~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4AJW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat" id="~~ligandDat~~">~~<scene name='pdbligand=VWN:2~~-[~~(1-METHYL-1H-BENZIMIDAZOL-~~2~~-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.8Å</td></tr>
-	<tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</div></td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
-	~~<tr~~ id~~='activity'><td class~~="~~sblockLbl~~"><~~b>Activity:</b></td><td class~~=~~"sblockDat"><span class~~=~~'plainlinks'>[https~~:~~//en.wikipedia.org/wiki/Phosphatidylinositol~~-~~4,5~~-~~bisphosphate_3~~-~~kinase Phosphatidylinositol~~-~~4,5~~-~~bisphosphate 3~~-~~kinase~~]~~, with EC number [https://www.brenda~~-~~enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153]~~ </~~span~~></td></tr>	+
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [https://pdbe.org/4ajw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [https://www.ebi.ac.uk/pdbsum/4ajw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajw ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [https://pdbe.org/4ajw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [https://www.ebi.ac.uk/pdbsum/4ajw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajw ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
-	[[https://www.uniprot.org/uniprot/PK3CD_MOUSE PK3CD_MOUSE]] Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function.<ref>PMID:12130661</ref> <ref>PMID:12235209</ref> <ref>PMID:15496927</ref> <ref>PMID:16116162</ref> <ref>PMID:18259608</ref> <ref>PMID:18809712</ref> <ref>PMID:19297623</ref>	+	[https://www.uniprot.org/uniprot/PK3CD_MOUSE PK3CD_MOUSE] Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function.<ref>PMID:12130661</ref> <ref>PMID:12235209</ref> <ref>PMID:15496927</ref> <ref>PMID:16116162</ref> <ref>PMID:18259608</ref> <ref>PMID:18809712</ref> <ref>PMID:19297623</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 28:		Line 27:
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Lk3 transgenic mice]]~~	+	[[Category: Mus musculus]]
-	~~[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase~~]]	+	[[Category: Abecassis PY]]
-	[[Category: Abecassis~~, P Y~~]]	+	[[Category: Angouillant-Boniface O]]
-	[[Category: Angouillant-Boniface, O]]	+	[[Category: Below P]]
-	[[Category: Below, P]]	+	[[Category: Benard T]]
-	[[Category: Benard, T]]	+	[[Category: Bertrand T]]
-	[[Category: Bertrand, T]]	+	[[Category: Bonnevaux H]]
-	[[Category: Bonnevaux, H]]	+	[[Category: Carry JC]]
-	[[Category: Carry~~, J C~~]]	+	[[Category: Certal V]]
-	[[Category: Certal, V]]	+	[[Category: Chatreaux F]]
-	[[Category: Chatreaux, F]]	+	[[Category: Delorme C]]
-	[[Category: Delorme, C]]	+	[[Category: El-Ahmad Y]]
-	[[Category: El-Ahmad, Y]]	+	[[Category: Filoche-Romme B]]
-	[[Category: Filoche-Romme, B]]	+	[[Category: Halley F]]
-	[[Category: Halley, F]]	+	[[Category: Karlsson A]]
-	[[Category: Karlsson, A]]	+	[[Category: Lebourg G]]
-	[[Category: Lebourg, G]]	+	[[Category: Lejeune P]]
-	[[Category: Lejeune, P]]	+	[[Category: Lengauer C]]
-	[[Category: Lengauer, C]]	+	[[Category: Louboutin A]]
-	[[Category: Louboutin, A]]	+	[[Category: Marquette JP]]
-	[[Category: Marquette~~, J P~~]]	+	[[Category: Michot N]]
-	[[Category: Michot, N]]	+	[[Category: Nicolas JP]]
-	[[Category: Nicolas~~, J P~~]]	+	[[Category: Pilorge F]]
-	[[Category: Pilorge, F]]	+	[[Category: Rak A]]
-	[[Category: Rak, A]]	+	[[Category: Schio L]]
-	[[Category: Schio, L]]	+	[[Category: Thompson F]]
-	[[Category: Thompson, F]]	+	[[Category: Vade I]]
-	[[Category: Vade, I]]	+	[[Category: Virone-Oddos A]]
-	[[Category: Virone-Oddos, A]]	+
-	~~[[Category: P110d]]~~	+
-	~~[[Category: Transferase~~]]	+

OCA at 05:36, 25 August 2022

2022-08-25T05:36:32Z

←Older revision		Revision as of 05:36, 25 August 2022
Line 3:		Line 3:
	<StructureSection load='4ajw' size='340' side='right'caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4ajw' size='340' side='right'caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4AJW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
-	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</div></td></tr>
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [~~http~~://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>	+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [~~http~~://pdbe.org/4ajw PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4ajw PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajw ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [https://pdbe.org/4ajw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [https://www.ebi.ac.uk/pdbsum/4ajw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajw ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
-	[[~~http~~://www.uniprot.org/uniprot/PK3CD_MOUSE PK3CD_MOUSE]] Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function.<ref>PMID:12130661</ref> <ref>PMID:12235209</ref> <ref>PMID:15496927</ref> <ref>PMID:16116162</ref> <ref>PMID:18259608</ref> <ref>PMID:18809712</ref> <ref>PMID:19297623</ref>	+	[[https://www.uniprot.org/uniprot/PK3CD_MOUSE PK3CD_MOUSE]] Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function.<ref>PMID:12130661</ref> <ref>PMID:12235209</ref> <ref>PMID:15496927</ref> <ref>PMID:16116162</ref> <ref>PMID:18259608</ref> <ref>PMID:18809712</ref> <ref>PMID:19297623</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 22:		Line 22:

	==See Also==		==See Also==
-	*[[Phosphoinositide 3-~~Kinases~~\|Phosphoinositide 3-~~Kinases~~]]	+	*[[Phosphoinositide 3-kinase 3D structures\|Phosphoinositide 3-kinase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 07:24, 24 April 2019

2019-04-24T07:24:49Z

←Older revision		Revision as of 07:24, 24 April 2019
Line 27:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Lk3 transgenic mice]]		[[Category: Lk3 transgenic mice]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]

OCA at 09:23, 6 March 2019

2019-03-06T09:23:38Z

←Older revision		Revision as of 09:23, 6 March 2019
Line 1:		Line 1:

	==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers==		==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers==
-	<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>	+	<StructureSection load='4ajw' size='340' side='right'caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>
Line 27:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Lk3 transgenic mice]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]
	[[Category: Abecassis, P Y]]		[[Category: Abecassis, P Y]]

OCA at 06:58, 29 March 2017

2017-03-29T06:58:01Z

←Older revision		Revision as of 06:58, 29 March 2017
Line 1:		Line 1:

-	==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"==	+	==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers==
	<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure ~~with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]~~. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>
Line 27:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: Lk3 transgenic mice]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]
	[[Category: Abecassis, P Y]]		[[Category: Abecassis, P Y]]

OCA at 23:27, 4 August 2016

2016-08-04T23:27:02Z

←Older revision		Revision as of 23:27, 4 August 2016
Line 1:		Line 1:
		+
	==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"==		==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"==
	<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>		<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Mus_musculus Mus musculus~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [http://www.ebi.ac.uk/pdbsum/4ajw PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [http://pdbe.org/4ajw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [http://www.ebi.ac.uk/pdbsum/4ajw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajw ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 18:		Line 19:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4ajw" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
Line 25:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Mus musculus~~]]	+	[[Category: Lk3 transgenic mice]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]
	[[Category: Abecassis, P Y]]		[[Category: Abecassis, P Y]]

OCA at 13:59, 25 December 2014

2014-12-25T13:59:10Z

←Older revision		Revision as of 13:59, 25 December 2014
Line 3:		Line 3:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>		<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
-	</td></tr><tr><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene><br>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene></td></tr>
-	<tr><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>
-	<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>	+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>
-	<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [http://www.ebi.ac.uk/pdbsum/4ajw PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [http://www.ebi.ac.uk/pdbsum/4ajw PDBsum]</span></td></tr>
-	<table>	+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/PK3CD_MOUSE PK3CD_MOUSE]] Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function.<ref>PMID:12130661</ref> <ref>PMID:12235209</ref> <ref>PMID:15496927</ref> <ref>PMID:16116162</ref> <ref>PMID:18259608</ref> <ref>PMID:18809712</ref> <ref>PMID:19297623</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 27:
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]
-	[[Category: Abecassis, P Y.]]	+	[[Category: Abecassis, P Y]]
-	[[Category: Angouillant-Boniface, O.]]	+	[[Category: Angouillant-Boniface, O]]
-	[[Category: Below, P.]]	+	[[Category: Below, P]]
-	[[Category: Benard, T.]]	+	[[Category: Benard, T]]
-	[[Category: Bertrand, T.]]	+	[[Category: Bertrand, T]]
-	[[Category: Bonnevaux, H.]]	+	[[Category: Bonnevaux, H]]
-	[[Category: Carry, J C.]]	+	[[Category: Carry, J C]]
-	[[Category: Certal, V.]]	+	[[Category: Certal, V]]
-	[[Category: Chatreaux, F.]]	+	[[Category: Chatreaux, F]]
-	[[Category: Delorme, C.]]	+	[[Category: Delorme, C]]
-	[[Category: El-Ahmad, Y.]]	+	[[Category: El-Ahmad, Y]]
-	[[Category: Filoche-Romme, B.]]	+	[[Category: Filoche-Romme, B]]
-	[[Category: Halley, F.]]	+	[[Category: Halley, F]]
-	[[Category: Karlsson, A.]]	+	[[Category: Karlsson, A]]
-	[[Category: Lebourg, G.]]	+	[[Category: Lebourg, G]]
-	[[Category: Lejeune, P.]]	+	[[Category: Lejeune, P]]
-	[[Category: Lengauer, C.]]	+	[[Category: Lengauer, C]]
-	[[Category: Louboutin, A.]]	+	[[Category: Louboutin, A]]
-	[[Category: Marquette, J P.]]	+	[[Category: Marquette, J P]]
-	[[Category: Michot, N.]]	+	[[Category: Michot, N]]
-	[[Category: Nicolas, J P.]]	+	[[Category: Nicolas, J P]]
-	[[Category: Pilorge, F.]]	+	[[Category: Pilorge, F]]
-	[[Category: Rak, A.]]	+	[[Category: Rak, A]]
-	[[Category: Schio, L.]]	+	[[Category: Schio, L]]
-	[[Category: Thompson, F.]]	+	[[Category: Thompson, F]]
-	[[Category: Vade, I.]]	+	[[Category: Vade, I]]
-	[[Category: Virone-Oddos, A.]]	+	[[Category: Virone-Oddos, A]]
	[[Category: P110d]]		[[Category: P110d]]
	[[Category: Transferase]]		[[Category: Transferase]]

OCA at 08:06, 5 June 2014

2014-06-05T08:06:53Z

←Older revision		Revision as of 08:06, 5 June 2014
Line 1:		Line 1:
-	[[~~Image:~~4ajw.~~png~~\|~~left~~\|~~200px~~]]	+	==Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"==
		+	<StructureSection load='4ajw' size='340' side='right' caption='[[4ajw]], [[Resolution\|resolution]] 2.80Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4AJW FirstGlance]. <br>
		+	</td></tr><tr><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=VWN:2-[(1-METHYL-1H-BENZIMIDAZOL-2-YL)METHYL]-6-MORPHOLIN-4-YLPYRIMIDIN-4(3H)-ONE'>VWN</scene><br>
		+	<tr><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[2wxe\|2wxe]], [[2wxf\|2wxf]], [[2wxg\|2wxg]], [[2wxh\|2wxh]], [[2wxi\|2wxi]], [[2wxj\|2wxj]], [[2wxk\|2wxk]], [[2wxl\|2wxl]], [[2wxm\|2wxm]], [[2wxn\|2wxn]], [[2wxo\|2wxo]], [[2wxp\|2wxp]], [[2wxq\|2wxq]], [[2wxr\|2wxr]], [[2x38\|2x38]]</td></tr>
		+	<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphatidylinositol-4,5-bisphosphate_3-kinase Phosphatidylinositol-4,5-bisphosphate 3-kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.153 2.7.1.153] </span></td></tr>
		+	<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ajw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ajw RCSB], [http://www.ebi.ac.uk/pdbsum/4ajw PDBsum]</span></td></tr>
		+	<table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Most of the phosphoinositide-3 kinase (PI3K) kinase inhibitors currently in clinical trials for cancer treatment exhibit pan PI3K isoform profiles. Single PI3K isoforms differentially control tumorigenesis, and PI3Kbeta has emerged as the isoform involved in the tumorigenicity of PTEN-deficient tumors. Herein we describe the discovery and optimization of a new series of benzimidazole- and benzoxazole-pyrimidones as small molecular mass PI3Kbeta-selective inhibitors. Starting with compound 5 obtained from a one-pot reaction via a novel intermediate 1, medicinal chemistry optimization led to the discovery of compound 8, which showed a significant activity and selectivity for PI3Kbeta and adequate in vitro pharmacokinetic properties. The X-ray costructure of compound 8 in PI3Kdelta showed key interactions and structural features supporting the observed PI3Kbeta isoform selectivity. Compound 8 achieved sustained target modulation and tumor growth delay at well tolerated doses when administered orally to SCID mice implanted with PTEN-deficient human tumor xenografts.

-	<!--	+	Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3Kbeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers.,Certal V, Halley F, Virone-Oddos A, Delorme C, Karlsson A, Rak A, Thompson F, Filoche-Romme B, El-Ahmad Y, Carry JC, Abecassis PY, Lejeune P, Vincent L, Bonnevaux H, Nicolas JP, Bertrand T, Marquette JP, Michot N, Benard T, Below P, Vade I, Chatreaux F, Lebourg G, Pilorge F, Angouillant-Boniface O, Louboutin A, Lengauer C, Schio L J Med Chem. 2012 May 2. PMID:22524426<ref>PMID:22524426</ref>
-	~~The line below this paragraph, containing "STRUCTURE_4ajw", creates the "Structure Box" on~~ the ~~page.~~	+
-	~~You may change the PDB parameter~~ (~~which sets the PDB file loaded into the applet~~)	+
-	~~or the SCENE parameter (which sets the initial scene displayed when the page is loaded),~~	+
-	~~or leave the SCENE parameter empty for the default display~~.	+
-	-->	+
-	~~{{STRUCTURE_4ajw\| PDB=4ajw \| SCENE= }}~~	+

-	~~===Discovery and Optimization~~ of ~~New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for~~ the ~~Treatment~~ of ~~Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"===~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>

-		+	==See Also==
-	~~<!--~~	+	*[[Phosphoinositide 3-Kinases\|Phosphoinositide 3-Kinases]]
-	~~The line below this paragraph, {{ABSTRACT_PUBMED_22524426}}, adds the Publication Abstract to the page~~	+	== References ==
-	~~(as it appears on PubMed at http://www.pubmed.gov), where 22524426 is the PubMed ID number.~~	+	<references/>
-	~~-->~~	+	__TOC__
-	~~{{ABSTRACT_PUBMED_22524426}}~~	+	</StructureSection>
-		+
-	==~~About this Structure~~==	+
-	[[~~4ajw~~]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA].	+
-		+
-	==~~Reference~~==	+
-	<~~ref group="xtra">PMID:022524426<~~/~~ref~~><~~references group="xtra"~~/>	+
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]		[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]

OCA at 06:51, 6 June 2012

2012-06-06T06:51:03Z

←Older revision		Revision as of 06:51, 6 June 2012
Line 1:		Line 1:
-	[[Image:4ajw.~~jpg~~\|left\|200px]]	+	[[Image:4ajw.png\|left\|200px]]

	<!--		<!--

OCA at 09:13, 16 May 2012

2012-05-16T09:13:14Z

←Older revision		Revision as of 09:13, 16 May 2012
Line 1:		Line 1:
-	~~'''Unreleased structure'''~~	+	[[Image:4ajw.jpg\|left\|200px]]

-	The ~~entry 4ajw~~ is ~~ON HOLD~~ ~~until Paper Publication~~	+	<!--
		+	The line below this paragraph, containing "STRUCTURE_4ajw", creates the "Structure Box" on the page.
		+	You may change the PDB parameter (which sets the PDB file loaded into the applet)
		+	or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
		+	or leave the SCENE parameter empty for the default display.
		+	-->
		+	{{STRUCTURE_4ajw\| PDB=4ajw \| SCENE= }}

-	~~Authors: Certal, V., Halley, F., Virone~~-~~Oddos, A., Delorme, C., Karlsson, A., Rak, A., Thompson, F., Filoche~~-~~Romme, B., El~~-Ahmad, Y., Carry, J.C., Abecassis, P.Y., Lejeune, P., Bonnevaux, H., Nicolas, J.P., Bertrand, T., Marquette, J.P., Michot, N., Benard, T., Below, P., Vade, I., Chatreaux, F., Lebourg, G., Pilorge, F., Angouillant-Boniface, O., Louboutin, A., Lengauer, C., Schio, L.	+	===Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3KBeta Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers"===

-	~~Description: Discovery and Optimization of New Benzimidazole~~-~~and Benzoxazole~~-~~Pyrimidone Selective PI3Kb Inhibitors for~~ the ~~Treatment of PTEN~~-~~Deficient Cancers~~	+
		+	<!--
		+	The line below this paragraph, {{ABSTRACT_PUBMED_22524426}}, adds the Publication Abstract to the page
		+	(as it appears on PubMed at http://www.pubmed.gov), where 22524426 is the PubMed ID number.
		+	-->
		+	{{ABSTRACT_PUBMED_22524426}}
		+
		+	==About this Structure==
		+	[[4ajw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJW OCA].
		+
		+	==Reference==
		+	<ref group="xtra">PMID:022524426</ref><references group="xtra"/>
		+	[[Category: Mus musculus]]
		+	[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]]
		+	[[Category: Abecassis, P Y.]]
		+	[[Category: Angouillant-Boniface, O.]]
		+	[[Category: Below, P.]]
		+	[[Category: Benard, T.]]
		+	[[Category: Bertrand, T.]]
		+	[[Category: Bonnevaux, H.]]
		+	[[Category: Carry, J C.]]
		+	[[Category: Certal, V.]]
		+	[[Category: Chatreaux, F.]]
		+	[[Category: Delorme, C.]]
		+	[[Category: El-Ahmad, Y.]]
		+	[[Category: Filoche-Romme, B.]]
		+	[[Category: Halley, F.]]
		+	[[Category: Karlsson, A.]]
		+	[[Category: Lebourg, G.]]
		+	[[Category: Lejeune, P.]]
		+	[[Category: Lengauer, C.]]
		+	[[Category: Louboutin, A.]]
		+	[[Category: Marquette, J P.]]
		+	[[Category: Michot, N.]]
		+	[[Category: Nicolas, J P.]]
		+	[[Category: Pilorge, F.]]
		+	[[Category: Rak, A.]]
		+	[[Category: Schio, L.]]
		+	[[Category: Thompson, F.]]
		+	[[Category: Vade, I.]]
		+	[[Category: Virone-Oddos, A.]]
		+	[[Category: P110d]]
		+	[[Category: Transferase]]